Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Alarm.com
ALRM
$2.74B
| $9.67M | 0.01% |
195,500
+2,900
| +2% | +$160K |
|
1102
Hims & Hers Health
HIMS
$6.71B
| $9.67M | 0.01% |
1,508,700
-6,100
| -0.4% | -$34.7K |
|
1103
Tucows
TCX
$140M
| $9.63M | 0.01% |
283,951
-28,724
| -9% | -$1.04M |
|
1104
Noble Corp
NE
$7.07B
| $9.63M | 0.01% |
+255,300
| New | +$9.08M |
|
1105
Hertz
HTZ
$838M
| $9.6M | 0.01% |
+623,600
| New | +$10.5M |
|
1106
Element Solutions
ESI
$9.51B
| $9.6M | 0.01% |
527,500
-31,700
| -6% | -$571K |
|
1107
Brookfield Infrastructure Partners
BIP
$18.2B
| $9.58M | 0.01% |
+309,000
| New | +$10.8M |
|
|
AJRD
1108
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $9.57M | 0.01% |
171,100
+15,400
| +10% | +$763K |
|
1109
iRhythm Holdings
IRTC
$4.06B
| $9.54M | 0.01% |
+101,800
| New | +$11.1M |
|
1110
Neogen
NEOG
$2.59B
| $9.54M | 0.01% |
626,036
-1,577,900
| -72% | -$22.5M |
|
1111
Copart
CPRT
$27.2B
| $9.49M | 0.01% |
311,800
-2,647,000
| -89% | -$79.2M |
|
1112
Silgan Holdings
SLGN
$4.3B
| $9.49M | 0.01% |
+183,080
| New | +$8.97M |
|
1113
Safe Bulkers
SB
$760M
| $9.43M | 0.01% |
3,239,386
-633,100
| -16% | -$1.75M |
|
1114
Barclays
BCS
$94.6B
| $9.41M | 0.01% |
+1,206,286
| New | +$8.8M |
|
|
CNH
1115
CNH Industrial
CNH
$16.7B
| $9.39M | 0.01% |
586,172
-1,204,928
| -67% | -$17.4M |
|
1116
Central Garden & Pet Co
CENT
$2.79B
| $9.39M | 0.01% |
313,514
-20,250
| -6% | -$641K |
|
1117
Tilly's
TLYS
$121M
| $9.36M | 0.01% |
1,034,112
-83,700
| -7% | -$735K |
|
1118
Mine Safety
MSA
$7.32B
| $9.36M | 0.01% |
64,900
+2,100
| +3% | +$275K |
|
1119
Moderna
MRNA
$25.4B
| $9.33M | 0.01% |
51,964
-911,077
| -95% | -$149M |
|
1120
KRONOS Worldwide
KRO
$905M
| $9.33M | 0.01% |
992,800
-115,400
| -10% | -$1.09M |
|
1121
Mitsubishi UFJ Financial
MUFG
$260B
| $9.33M | 0.01% |
1,398,400
-281,500
| -17% | -$1.46M |
|
|
AGEN
1122
Agenus
AGEN
$315M
| $9.32M | 0.01% |
197,896
-63,499
| -24% | -$3.23M |
|
1123
StepStone Group
STEP
$3.96B
| $9.32M | 0.01% |
370,100
-108,900
| -23% | -$3.04M |
|
1124
Zurn Elkay Water Solutions
ZWS
$8.41B
| $9.29M | 0.01% |
+439,193
| New | +$10.4M |
|
1125
GFL Environmental
GFL
$14.7B
| $9.28M | 0.01% |
317,347
-138,923
| -30% | -$3.77M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.